Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Blum
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- Blood and Marrow Transplant Group of Georgia
Atlanta, Georgia, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- University of Illinois
Chicago, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Fort Wayne Medical Oncology and Hematology Inc-Parkview
Fort Wayne, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Eastern Maine Medical Center
Bangor, Maine, United States
- University of Maryland/greenebaum Cancer Center
Baltimore, Maryland, United States
- Walter Reed National Military Medical Center
Bethesda, Maryland, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Commonwealth Hematology Oncology Pc-Worcester
Worcester, Massachusetts, United States
- University of Missouri - Ellis Fischel
Columbia, Missouri, United States
- Veterans Administration
Columbia, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Great Plains Health Callahan Cancer Center
North Platte, Nebraska, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Nevada Cancer Research Foundation Ccop
Las Vegas, Nevada, United States
- Sunrise Hospital and Medical Center
Las Vegas, Nevada, United States
- University Medical Center of Southern Nevada
Las Vegas, Nevada, United States
- Cheshire Medical Center-Dartmouth-Hitchcock Keene
Keene, New Hampshire, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
- Cooper Hospital University Medical Center
Camden, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Northwell Health Ncorp
Lake Success, New York, United States
- Northwell Health/center for Advanced Medicine
Lake Success, New York, United States
- North Shore University Hospital
Manhasset, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- Mount Sinai Hospital
New York, New York, United States
- State University of New York Upstate Medical University
Syracuse, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Wayne Memorial Hospital
Goldsboro, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2006
- Primary completion
- 31 Jan 2011
- Completion
- 1 Dec 2016
- Last update posted
- 19 Feb 2019
- Registered enrollment
- 546
- Registry id
- NCT00416598
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.